Preferred Label : ponesimod;

MeSH note : structure in first source;

CISMeF synonym : ACT 128800;

MeSH synonym : 5-(3-chloro-4-(2,3-dihydroxy-propoxy)benzylidene)-2-propylimino-3-o-tolyl-thiazolidin-4-one;

MeSH hyponym : ACT128800; ACT-128800;

Is substance : O;

UNII : 5G7AKV2MKP;

InChIKey : LPAUOXUZGSBGDU-STDDISTJSA-N;

Details


Main resources

You can consult :


https://ansm.sante.fr/tableau-marr/ponesimod
2024
false
false
false
France
French
risk management
ponesimod
ponesimod
administration, oral
ponesimod
ponvory
guidelines for drug use
patients guideline
pregnancy
continuity of patient care
ponesimod
adult
multiple sclerosis, relapsing-remitting
drug monitoring
immunosuppressive agents
immunosuppressive agents
immunosuppressive agents

---
https://www.has-sante.fr/jcms/p_3410988/fr/ponvory-ponesimod-sclerose-en-plaques
2023
false
false
false
France
administration, oral
ponesimod
withdrawing treatment
Medication set-up education, guidance, and counseling (procedure)
evaluation of the transparency committee
multiple sclerosis, relapsing-remitting
ponesimod

---
https://www.ema.europa.eu/en/medicines/human/EPAR/ponvory
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
ponesimod
ponesimod
drug approval
europe
ponesimod
Sphingosine 1 Phosphate Receptor Modulators
Sphingosine 1 Phosphate Receptor Modulators
multiple sclerosis, relapsing-remitting
adult
administration, oral
drug monitoring
aged
drug interactions
pregnancy
breast feeding
Female of Childbearing Potential
drug evaluation, preclinical
thiazoles
thiazoles

---
https://www.has-sante.fr/jcms/p_3284793/fr/ponvory-ponesimod
2021
false
false
false
France
evaluation of the transparency committee
thiazoles
thiazoles
treatment outcome
multiple sclerosis, relapsing-remitting
insurance, health, reimbursement
ponesimod
ponesimod
Sphingosine 1 Phosphate Receptor Modulators
Sphingosine 1 Phosphate Receptor Modulators
adult
ponesimod
administration, oral

---
Nous contacter.
03/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.